Skip to main content
Log in

Is it Time for Reporting Guidelines for Calibration Methods?

  • Commentary
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Stout NK, Knudsen AB, Kong CY, et al. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics 2009; 27 (7): 533–45

    Article  PubMed  Google Scholar 

  2. Goldhaber-Fiebert JD, Stout NK, Ortendahl J, et al. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr 2007; 5 (1): 11

    Article  PubMed  Google Scholar 

  3. STARD Statement. STAndards for the Reporting of Diagnostic accuracy studies [online]. Available from URL: http://www.stard-statement.org/ [Accessed 2009 Apr 22]

  4. Moher D, Schulz KF, Altman DG, for the CONSORT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657–62

    PubMed  CAS  Google Scholar 

  5. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313 (7052): 275–83

    Article  PubMed  CAS  Google Scholar 

  6. Weinstein MC, O’Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices – Modeling Studies. Value Health 2003 Jan-Feb; 6 (1): 9–17

    Article  PubMed  Google Scholar 

  7. Cantor SB, Ganiats TG. Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. J Clin Epidemiol 1999 Jun; 52 (6): 517–22

    Article  PubMed  CAS  Google Scholar 

  8. Richardson WS, Detsky AS. Users’ guides to the medical literature: VII. How to use a clinical decision analysis: A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1995 Apr 26; 273 (16): 1292–5

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The author acknowledges the editorial suggestions of Rebecca Partida. The author has no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott B. Cantor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cantor, S.B. Is it Time for Reporting Guidelines for Calibration Methods?. Pharmacoeconomics 27, 529–531 (2009). https://doi.org/10.2165/11316900-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11316900-000000000-00000

Keywords

Navigation